BOSTON (AP) — BOSTON (AP) — Haemonetics Corp. (HAE) on Thursday reported fiscal third-quarter net income of $37.5 million.
The Boston-based company said it had net income of 74 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.19 per share.
The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for earnings of $1.19 per share.
The provider blood management systems for health care providers and blood collectors posted revenue of $348.5 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $353.1 million.
Haemonetics expects full-year earnings in the range of $4.50 to $4.70 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HAE at https://www.zacks.com/ap/HAE
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.